Related Experiment Video
Updated: Nov 14, 2025

Functional Characterization of Endogenously Expressed Human RYR1 Variants
Published on: June 9, 2021
Malignant Hyperthermia-Associated Rhabdomyolysis After Succinylcholine: A Case Report
Jaelin J Otta1, Lisa Ohden2, Douglas G Bell3,4
1University of South Dakota Sanford School of Medicine.
Abstract:
Malignant hyperthermia-associated rhabdomyolysis is a condition that lies on the spectrum of malignant hyperthermia (MH). Unlike MH, malignant-hyperthermia-associated rhabdomyolysis is a condition which most commonly is recognized in the postoperative period by the development of discolored brown urine with notably absent rigidity, tachypnea, tachycardia, and hyperthermia. The presented case describes the subtle onset of malignant hyperthermia-associated rhabdomyolysis, along with a review of relevant literature.
Related Concept Videos
Depolarizing Blockers: Pharmocokinetics
Skeletal Muscle Relaxants: Adverse Effects
Unlike...
Depolarizing Blockers: Mechanism of Action
Succinylcholine is the most commonly used depolarizing blocker. Chemically, it constitutes two molecules of acetylcholine joined together by an acetate methyl group. They act on the receptors in the same way as acetylcholine. Because...
Skeletal Muscle Relaxants: Therapeutic Uses
Anticholinesterase Agents: Poisoning and Treatment
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is...
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacological Actions
Although all competitive neuromuscular blockers are designed...

